These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 17931480

  • 21. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.
    Kobelt G, Canning DA, Hensle TW, Läckgren G.
    J Urol; 2003 Apr; 169(4):1480-4; discdussion 1484-5. PubMed ID: 12629396
    [Abstract] [Full Text] [Related]

  • 22. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH, Tsai MH, Huang YC, Su LH, Tsau YK, Lin CJ, Chiu CH, Lin TY.
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [Abstract] [Full Text] [Related]

  • 23. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study.
    Stenbäck A, Olafsdottir T, Sköldenberg E, Barker G, Stenberg A, Läckgren G.
    J Pediatr Urol; 2020 Jun; 16(3):328.e1-328.e9. PubMed ID: 32414615
    [Abstract] [Full Text] [Related]

  • 24. Comparison and clinical analysis of antibiotics and endoscopic injection for vesicoureteral reflux in children.
    Yang Z, Dai K, Sun X, Tian C, Yuan L, Liu J, Li B, Chung PHY, Wong KKY.
    Pediatr Surg Int; 2024 Jul 12; 40(1):184. PubMed ID: 38995440
    [Abstract] [Full Text] [Related]

  • 25. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux.
    Chi A, Gupta A, Snodgrass W.
    J Urol; 2008 May 12; 179(5):1966-9. PubMed ID: 18355849
    [Abstract] [Full Text] [Related]

  • 26. Subureteral dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux in transplant candidates.
    Ozok U, Eroglu M, Imamoglu A, Bakirtaş H, Güvence N, Kiper A.
    J Endourol; 2005 Dec 12; 19(10):1185-7. PubMed ID: 16359211
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The deflux procedure reduces the incidence of urinary tract infections in patients with vesicoureteral reflux.
    Wadie GM, Tirabassi MV, Courtney RA, Moriarty KP.
    J Laparoendosc Adv Surg Tech A; 2007 Jun 12; 17(3):353-9. PubMed ID: 17570788
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Endoscopic treatment of vesicoureteral reflux using dextranomer hyaluronic acid copolymer.
    Molitierno JA, Scherz HC, Kirsch AJ.
    J Pediatr Urol; 2008 Jun 12; 4(3):221-8. PubMed ID: 18631931
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation.
    Elmore JM, Kirsch AJ, Heiss EA, Gilchrist A, Scherz HC.
    J Urol; 2008 Jun 12; 179(6):2364-7; discussion 2367-8. PubMed ID: 18436248
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.